{
    "root": "341d13f4-5f86-3612-7628-d09a79640343",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "LOJAIMIESS",
    "value": "20240916",
    "ingredients": [],
    "indications": "lojaimiess combination levonorgestrel , progestin , ethinyl estradiol , estrogen , indicated females reproductive potential prevent pregnancy . ( 1 )",
    "contraindications": "take one tablet daily mouth time every day 91 days order directed blister pack . ( 2 )",
    "warningsAndPrecautions": "lojaimiess ( levonorgestrel ethinyl estradiol tablets , usp ethinyl estradiol tablets , usp ) available extended-cycle tablet blister pack contains 84 round , white off-white tablets 7 round , light peach tablets . white off-white tablet ( debossed 214 one side side plain ) contains 0.1 mg levonorgestrel 0.02 mg ethinyl estradiol . light peach tablet ( debossed 215 one side side plain ) contains 0.01 mg ethinyl estradiol . carton 2 pouches ( ndc 70700-207-93 ) ; pouch ( ndc 70700-207-87 ) contains 91 tablets extended-cycle tablet blister pack . storage store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) . [ usp controlled room temperature . ] tablets removed protective blister packaging avoid damage product . blister pack kept foil pouch dispensed patient .",
    "adverseReactions": "high risk arterial venous thrombotic diseases ( 4 ) undiagnosed abnormal uterine bleeding ( 4 ) breast cancer ( 4 ) liver tumors liver disease , acute viral hepatitis decompensated cirrhosis ( 4 ) co-administration hepatitis c combinations containing ombitasvir/paritaprevir/ritonavir , without dasabuvir , ( 4 )",
    "indications_original": "LoJaimiess is a combination of levonorgestrel, a progestin, and ethinyl estradiol, an estrogen, indicated for use by females of reproductive potential to prevent pregnancy. ( 1 )",
    "contraindications_original": "Take one tablet daily by mouth at the same time every day for 91 days in the order directed on the blister pack. ( 2 )",
    "warningsAndPrecautions_original": "LoJaimiess (Levonorgestrel and Ethinyl Estradiol Tablets, USP and Ethinyl Estradiol Tablets, USP) is available in an Extended-Cycle Tablet Blister Pack that contains 84 round, white to off-white tablets and 7 round, light peach tablets. Each white to off-white tablet (debossed with\u00a0214\u00a0on one side and other side plain) contains 0.1 mg levonorgestrel and 0.02 mg ethinyl estradiol. Each light peach tablet (debossed with\u00a0215\u00a0on one side and other side plain) contains 0.01 mg ethinyl estradiol.\n                  Carton of 2 pouches (NDC 70700-207-93); each pouch (NDC 70700-207-87) contains 91 tablets Extended-Cycle Tablet Blister Pack.\n                  \n                     Storage\n                  \n                  \n                     Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F). [See USP Controlled Room Temperature.]\n                  \n                  The tablets should not be removed from the protective blister packaging to avoid damage to the product. The blister pack should be kept in the foil pouch until dispensed to the patient.",
    "adverseReactions_original": "A high risk of arterial or venous thrombotic diseases ( 4 ) Undiagnosed abnormal uterine bleeding ( 4 ) Breast cancer ( 4 ) Liver tumors or liver disease, acute viral hepatitis or decompensated cirrhosis ( 4 ) Co-administration with Hepatitis C drug combinations containing ombitasvir/paritaprevir/ritonavir, with or without dasabuvir, ( 4 )"
}